NR667-,/.CEA,/.FNP
1. A,/.patient,/.currently,/.undergoing,/.concurrent,/.chemotherapy/radiation ,/.treat-
ment,/.for,/.glottic,/.squamous,/.cell,/.carcinoma,/.is,/.admitted,/.to,/.the,/.rehab,/.unit,/.you,/.
oversee, / . for, / . management, / . of, / . intractable, / . nausea,, / . vomiting,, / . and, / . deh
ydration.,/.Admission,/.CBC,/.showed,/.WBC,/.1.3,,/.Hgb,/.7.5,,/.PLT,/.45,,/.ANC,/.0.8.,/.Whic
h,/.of,/.the,/.following,/.conditions,/.is,/.this,/.patient,/.at,/.risk,/.for?
A. Macrocytic,/.anemia,/.due,/.to,/.B12,/.deficiency
B. Iron,/. deficiency,/. anemia,/. due,/. to,/. chronic,/. blood,/. loss
C. Microcytic,/.anemia,/.due,/.to,/.chronic,/.kidney,/.disease
D. Aplastic,/.anemia,/.due,/.to,/.bone,/.marrow,/.suppression:,/.D
2. Your,/.patient,/.presents,/.to,/.the,/.urgent,/.care,/.clinic,/.with,/.a,/.swollen,/.exudative,/.p
harynx,,/.profound,/.fatigue,,/.and,/.a,/.very,/.tender,/.left,/.upper,/.quadrant,/.abdomen.,/.
What,/.is,/.the,/.most,/.likely,/.diagnosis?
A. Strep,/.pharyngitis
B. Tonsillitis
C. Epstein,/.Barr,/.virus,/.(EBV)
D. Pancreatitis:, / . C
3. Which,/.of,/.the,/.following,/.best,/.characterizes,/.presbycusis,/.in,/.the,/.older,/.adult?
A. Bilateral, / . low-frequency, / . sensorineural, / . hearing, / . loss
B. Bilateral, / . high-frequency, / . sensorineural, / . hearing, / . loss
C. Unilateral, / . high-frequency, / . sensorineural, / . hearing, / . loss
D. Unilateral, / . low-frequency, / . sensorineural, / . hearing, / . loss:, / . B
4. A, / . 35-year-
old, / . woman, / . presents, / . with, / . allergic, / . rhinitis,, / . experiencing, / . significant, / . nasal, / .
congestion,, / . sneezing,, / . and, / . itchy, / . eyes., / . She, / . has, / . tried, / . over-the-
counter,/.antihistamines,/.with,/.limited,/.relief.,/.What,/.is,/.the,/.most,/.appropriate,/.ne
xt,/.step,/.in,/.management?
A. Oral,/.decongestants
B. Nasal, / . saline, / . irrigation
, NR667-,/.CEA,/.FNP
C. Intranasal, / . corticosteroids
D. Referral, / . to, / . an, / . allergist, / . for, / . immunotherapy:, / . C
5. A,/.patient,/.currently,/.undergoing,/.concurrent,/.chemotherapy/radiation ,/.treat-
ment,/.for,/.glottic,/.squamous,/.cell,/.carcinoma,/.is,/.admitted,/.to,/.the,/.rehab,/.unit,/.you,/.
oversee, / . for, / . management, / . of, / . intractable, / . nausea,, / . vomiting,, / . and, / . deh
ydration.,/.Admission,/.CBC,/.showed,/.WBC,/.1.3,,/.Hgb,/.7.5,,/.PLT,/.45,,/.ANC,/.0.8.,/.Whic
h,/.of,/.the,/.following,/.conditions,/.is,/.this,/.patient,/.at,/.risk,/.for?
A. Iron,/. deficiency,/. anemia,/. due,/. to,/. chronic,/. blood,/. loss
B. Microcytic,/.anemia,/.due,/.to,/.chronic,/.kidney,/.disease
C. Macrocytic,/.anemia,/.due,/.to,/.B12,/.deficiency
D. Aplastic,/.anemia,/.due,/.to,/.bone,/.marrow,/.suppression:,/.D
6. A,/.78,/.y.o.,/.M,/.patient,/.reports,/.chronic,/.infections,,/.bruising,,/.fatigue,,/.SOB,,/.and,/.f
evers., / . He, / . has, / . a, / . history, / . of, / . rectal, / . adenocarcinoma, / . and, / . completed, / . conc
urrent,/.chemotherapy/radiation,/.earlier,/.this,/.year.,/.His,/.CBC,/.shows,/.Hgb,/.7.5,,/.PLT,/.
88,,/.WBC,/.1.2,, / . ANC, / . 0.8,, / . and, / . peripheral, / . smear, / . shows, / . dysplasia., / . What, / . a
dditional, / . work-up,/.would,/.you,/.anticipate,/.for,/.this,/.patient?
A. Colonoscopy,/.and,/.fecal,/.occult,/.blood,/.test
B. Bone, / . marrow, / . biopsy, / . and, / . flow, / . cytometry
C. No, / . additional, / . work-
up, / . is, / . required,, / . these, / . are, / . expected, / . sequela, / . of, / . his, / . onco-logic,/.treatment
D. Repeat, / . CBC/CMP/peripheral, / . smear, / . in, / . eight, / . weeks:, / . B
7. Progression,/.to,/.Acute,/.Myelogenous,/.Leukemia,/.(AML),/.is,/.a,/.risk,/.for,/.untreated,/.or,/
.poorly,/.responsive:
A. Pancytopenia
B. Aplastic,/.anemia
C. Macrocytic,/.anemia
D. Myelodysplastic, / . syndrome:, / . D
8. Treatment, / . for, / . symptomatic, / . aplastic, / . anemia, / . includes, / . all, / . the, / . foll
owing, / . ex-cept:
, NR667-,/.CEA,/.FNP
A. Bone, / . marrow, / . transplant
B. PRBC/Platelet/WBC,/.transfusions
C. Prophylactic,/.antibiotics
D. Removal,/. of,/. bone,/. marrow,/. stimulants:,/. D
9. A,/.patient,/.diagnosed,/.with,/.iron,/.deficiency,/.anemia,/.requires,/.iron,/.supplemen
-
tation., / . Which, / . of, / . the, / . following, / . treatments, / . would, / . likely, / . be, / . ineffective
?
A. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.BID,/.for,/.a,/.43,/.y.o.,/.F,/.s/p,/.gastric,/.bypass,/.2,/.years,/.
ago
B. Iron,/.sucrose,/.200,/.mg,/.IV,/.infusion,/.weekly,/.x,/.8,/.weeks,/.in,/.a,/.26,/.y.o.,/.F,/.at,/.34,/.weeks,/.
of,/.pregnancy
C. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.TID,/.for,/.a,/.25,/.y.o.,/.F,/.with,/.menorrhagia
D. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.BID,/.for,/.a,/.63,/.y.o.,/.M,/.with,/.ulcerative,/.colitis:,/.A
10. Which,/.of,/.the,/.following,/.is,/.not,/.a,/.common,/.mechanism,/.of,/.neutrophil,/.expend
i-ture,/.and,/.resultant,/.neutropenia?
A. Decreased, / . neutrophil, / . production, / . in, / . the, / . bone, / . marrow
B. Redistribution, / . of, / . neutrophils, / . to, / . the, / . spleen, / . or, / . vascular, / . endotheliu
m
C. Loss, / . of, / . circulating, / . neutrophils, / . in, / . acute, / . blood, / . loss
D. Immune, / . destruction: , / . C
11. Which,/.of,/.the,/.following,/.blood,/.lead,/.levels,/.(BLL),/.would,/.likely,/.require,/.chelatio
n,/.therapy?
A. <,/.80,/.mcg/dL
B. 35,/.mcg/dL
C. >100,/.mcg/dL
D. 75, / . mcg/dL:, / . C
12. A, / . geriatric, / . patient, / . with, / . anemia,, / . back, / . pain,, / . osteoporosis,, / . and, / . ele
vated,/.erythrocyte,/.sedimentation,/.rate,/.should,/.be,/.evaluated,/.for:
, NR667-,/.CEA,/.FNP
A. cauda,/.equina,/.syndrome.
B. renal,/.dystrophy.
1. A,/.patient,/.currently,/.undergoing,/.concurrent,/.chemotherapy/radiation ,/.treat-
ment,/.for,/.glottic,/.squamous,/.cell,/.carcinoma,/.is,/.admitted,/.to,/.the,/.rehab,/.unit,/.you,/.
oversee, / . for, / . management, / . of, / . intractable, / . nausea,, / . vomiting,, / . and, / . deh
ydration.,/.Admission,/.CBC,/.showed,/.WBC,/.1.3,,/.Hgb,/.7.5,,/.PLT,/.45,,/.ANC,/.0.8.,/.Whic
h,/.of,/.the,/.following,/.conditions,/.is,/.this,/.patient,/.at,/.risk,/.for?
A. Macrocytic,/.anemia,/.due,/.to,/.B12,/.deficiency
B. Iron,/. deficiency,/. anemia,/. due,/. to,/. chronic,/. blood,/. loss
C. Microcytic,/.anemia,/.due,/.to,/.chronic,/.kidney,/.disease
D. Aplastic,/.anemia,/.due,/.to,/.bone,/.marrow,/.suppression:,/.D
2. Your,/.patient,/.presents,/.to,/.the,/.urgent,/.care,/.clinic,/.with,/.a,/.swollen,/.exudative,/.p
harynx,,/.profound,/.fatigue,,/.and,/.a,/.very,/.tender,/.left,/.upper,/.quadrant,/.abdomen.,/.
What,/.is,/.the,/.most,/.likely,/.diagnosis?
A. Strep,/.pharyngitis
B. Tonsillitis
C. Epstein,/.Barr,/.virus,/.(EBV)
D. Pancreatitis:, / . C
3. Which,/.of,/.the,/.following,/.best,/.characterizes,/.presbycusis,/.in,/.the,/.older,/.adult?
A. Bilateral, / . low-frequency, / . sensorineural, / . hearing, / . loss
B. Bilateral, / . high-frequency, / . sensorineural, / . hearing, / . loss
C. Unilateral, / . high-frequency, / . sensorineural, / . hearing, / . loss
D. Unilateral, / . low-frequency, / . sensorineural, / . hearing, / . loss:, / . B
4. A, / . 35-year-
old, / . woman, / . presents, / . with, / . allergic, / . rhinitis,, / . experiencing, / . significant, / . nasal, / .
congestion,, / . sneezing,, / . and, / . itchy, / . eyes., / . She, / . has, / . tried, / . over-the-
counter,/.antihistamines,/.with,/.limited,/.relief.,/.What,/.is,/.the,/.most,/.appropriate,/.ne
xt,/.step,/.in,/.management?
A. Oral,/.decongestants
B. Nasal, / . saline, / . irrigation
, NR667-,/.CEA,/.FNP
C. Intranasal, / . corticosteroids
D. Referral, / . to, / . an, / . allergist, / . for, / . immunotherapy:, / . C
5. A,/.patient,/.currently,/.undergoing,/.concurrent,/.chemotherapy/radiation ,/.treat-
ment,/.for,/.glottic,/.squamous,/.cell,/.carcinoma,/.is,/.admitted,/.to,/.the,/.rehab,/.unit,/.you,/.
oversee, / . for, / . management, / . of, / . intractable, / . nausea,, / . vomiting,, / . and, / . deh
ydration.,/.Admission,/.CBC,/.showed,/.WBC,/.1.3,,/.Hgb,/.7.5,,/.PLT,/.45,,/.ANC,/.0.8.,/.Whic
h,/.of,/.the,/.following,/.conditions,/.is,/.this,/.patient,/.at,/.risk,/.for?
A. Iron,/. deficiency,/. anemia,/. due,/. to,/. chronic,/. blood,/. loss
B. Microcytic,/.anemia,/.due,/.to,/.chronic,/.kidney,/.disease
C. Macrocytic,/.anemia,/.due,/.to,/.B12,/.deficiency
D. Aplastic,/.anemia,/.due,/.to,/.bone,/.marrow,/.suppression:,/.D
6. A,/.78,/.y.o.,/.M,/.patient,/.reports,/.chronic,/.infections,,/.bruising,,/.fatigue,,/.SOB,,/.and,/.f
evers., / . He, / . has, / . a, / . history, / . of, / . rectal, / . adenocarcinoma, / . and, / . completed, / . conc
urrent,/.chemotherapy/radiation,/.earlier,/.this,/.year.,/.His,/.CBC,/.shows,/.Hgb,/.7.5,,/.PLT,/.
88,,/.WBC,/.1.2,, / . ANC, / . 0.8,, / . and, / . peripheral, / . smear, / . shows, / . dysplasia., / . What, / . a
dditional, / . work-up,/.would,/.you,/.anticipate,/.for,/.this,/.patient?
A. Colonoscopy,/.and,/.fecal,/.occult,/.blood,/.test
B. Bone, / . marrow, / . biopsy, / . and, / . flow, / . cytometry
C. No, / . additional, / . work-
up, / . is, / . required,, / . these, / . are, / . expected, / . sequela, / . of, / . his, / . onco-logic,/.treatment
D. Repeat, / . CBC/CMP/peripheral, / . smear, / . in, / . eight, / . weeks:, / . B
7. Progression,/.to,/.Acute,/.Myelogenous,/.Leukemia,/.(AML),/.is,/.a,/.risk,/.for,/.untreated,/.or,/
.poorly,/.responsive:
A. Pancytopenia
B. Aplastic,/.anemia
C. Macrocytic,/.anemia
D. Myelodysplastic, / . syndrome:, / . D
8. Treatment, / . for, / . symptomatic, / . aplastic, / . anemia, / . includes, / . all, / . the, / . foll
owing, / . ex-cept:
, NR667-,/.CEA,/.FNP
A. Bone, / . marrow, / . transplant
B. PRBC/Platelet/WBC,/.transfusions
C. Prophylactic,/.antibiotics
D. Removal,/. of,/. bone,/. marrow,/. stimulants:,/. D
9. A,/.patient,/.diagnosed,/.with,/.iron,/.deficiency,/.anemia,/.requires,/.iron,/.supplemen
-
tation., / . Which, / . of, / . the, / . following, / . treatments, / . would, / . likely, / . be, / . ineffective
?
A. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.BID,/.for,/.a,/.43,/.y.o.,/.F,/.s/p,/.gastric,/.bypass,/.2,/.years,/.
ago
B. Iron,/.sucrose,/.200,/.mg,/.IV,/.infusion,/.weekly,/.x,/.8,/.weeks,/.in,/.a,/.26,/.y.o.,/.F,/.at,/.34,/.weeks,/.
of,/.pregnancy
C. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.TID,/.for,/.a,/.25,/.y.o.,/.F,/.with,/.menorrhagia
D. Ferrous,/.sulfate,/.325,/.mg,/.PO,/.BID,/.for,/.a,/.63,/.y.o.,/.M,/.with,/.ulcerative,/.colitis:,/.A
10. Which,/.of,/.the,/.following,/.is,/.not,/.a,/.common,/.mechanism,/.of,/.neutrophil,/.expend
i-ture,/.and,/.resultant,/.neutropenia?
A. Decreased, / . neutrophil, / . production, / . in, / . the, / . bone, / . marrow
B. Redistribution, / . of, / . neutrophils, / . to, / . the, / . spleen, / . or, / . vascular, / . endotheliu
m
C. Loss, / . of, / . circulating, / . neutrophils, / . in, / . acute, / . blood, / . loss
D. Immune, / . destruction: , / . C
11. Which,/.of,/.the,/.following,/.blood,/.lead,/.levels,/.(BLL),/.would,/.likely,/.require,/.chelatio
n,/.therapy?
A. <,/.80,/.mcg/dL
B. 35,/.mcg/dL
C. >100,/.mcg/dL
D. 75, / . mcg/dL:, / . C
12. A, / . geriatric, / . patient, / . with, / . anemia,, / . back, / . pain,, / . osteoporosis,, / . and, / . ele
vated,/.erythrocyte,/.sedimentation,/.rate,/.should,/.be,/.evaluated,/.for:
, NR667-,/.CEA,/.FNP
A. cauda,/.equina,/.syndrome.
B. renal,/.dystrophy.
